Bradley Pharmaceuticals Overview

  • Founded
  • 1985
  • Status
  • Acquired/​Merged
  • Employees
  • 300
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 3

Bradley Pharmaceuticals General Information


Operator of a specialty pharmaceutical company. The company markets to niche physician specialties in the U.S. and international markets. The company commercializes brands, develops new products through lifecycle management and in-licenses phase II and phase III drugs with long-term intellectual property protection. It specializes in pharmaceuticals for dermatology, podiatry, gastroenterology, women's health, respiratory and internal medicine products.

Contact Information

Ownership Status
Financing Status
Formerly PE-Backed
Primary Industry
Primary Office
  • 383 Route 46 West
  • Fairfield, NJ 07004
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bradley Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bradley Pharmaceuticals‘s full profile, request access.

Request a free trial

Bradley Pharmaceuticals Executive Team (2)

Name Title Board Seat Contact Info
Daniel Glassman President & Chief Executive Officer & Founder
Brent Lenczycki Chief Financial Officer & Vice President
To view Bradley Pharmaceuticals’s complete executive team members history, request access »

Bradley Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial